FIA
SNTI icon

FNY Investment Advisers’s Senti Biosciences Holdings SNTI Stock Holding History

FNY Investment Advisers’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-350
Closed -$7K – 732
2022
Q3 		$7K Hold
350
– – ﹤0.01% 430
2022
Q2 		$6K Sell
350
-240
-41% -$19.3K ﹤0.01% 490
2022
Q1 		$58K Sell
590
-15,418
-96% -$1.52M 0.05% 227
2021
Q4 		$1.58M Sell
16,008
-7,752
-33% -$773K 0.85% 21
2021
Q3 		$2.36M Buy
+23,760
New +$2.34M 1.1% 24

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

FNY Investment Advisers's SNTI Position: Q4 2022 in Review

FNY Investment Advisers sold out of Senti Biosciences Holdings (SNTI) in Q4 2022, closing a stake of 350 shares — an estimated $7K sold.

FNY Investment Advisers first reported a position in SNTI in Q3 2021 and held it in 5 quarters. The position peaked at $2.36M in Q3 2021. 26 funds tracked by Wall St. Rank hold SNTI as of Q4 2022.

  • FNY Investment Advisers reported no remaining Senti Biosciences Holdings position as of Q4 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 350 Senti Biosciences Holdings shares in Q4 2022, an estimated $7K.
  • FNY Investment Advisers first reported a position in Senti Biosciences Holdings in Q3 2021 and held it in 5 quarters.
  • FNY Investment Advisers's Senti Biosciences Holdings position peaked at $2.36M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2022.

Based on FNY Investment Advisers's 13F filing for Q4 2022, filed 10 Jan 2023.